| Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells. | ovarian, |
| Identification and structural analysis of human RBM8A and RBM8B: two highly conserved RNA-binding motif proteins that interact with OVCA1, a candidate tumor suppressor. | None |
| Ovca1 is a tumor suppressor that can modify p53-induced tumorigenesis and suggest that it acts as a positive regulator for cell cycle progression. | None |
| OVCA1: emerging as a bona fide tumor suppressor. | None |
| Gene trap mutagenesis-based forward genetic approach reveals that the tumor suppressor OVCA1 is a component of the biosynthetic pathway of diphthamide on elongation factor 2. | None |
| OVCA1: tumor suppressor gene. | None |
| The tumor suppressor OVCA1 is a short half-life protein degraded by the ubiquitin-proteasome pathway | None |
| Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Using allelic loss mapping and positional cloning methods, we have recently identified two novel genes, which we refer to as OVCA1 and OVCA2, that map to 17p13.3. | None |
| DPH1 functions as an oncogene in CRC and can be negatively modulated by miR-218-5p to promote CRC tumourigenesis. | None |